Why the study?
Does renal denervation improve ambulatory blood pressure, arterial stiffness, and peripheral resistance in patients with treatment resistant hypertension?
Population
94 patients with treatment resistant hypertension (TRH)
Design
Cohort
Follow-up
12 months
Key result
Renal denervation significantly reduced brachial and central ambulatory blood pressure (P<.001) and improved arterial stiffness and total vascular resistance at up to 12 months.
Authors
Loading...
Supports renal denervation evaluation in resistant hypertension; leaves open randomized confirmation of ambulatory BP and vascular benefits.
Cohort (n=94)
Does renal denervation improve ambulatory blood pressure, arterial stiffness, and peripheral resistance in patients with treatment resistant hypertension?
p-value: p=<.001
Renal denervation significantly reduces brachial and central ambulatory blood pressure, arterial stiffness, and total vascular resistance up to 12 months in patients with treatment-resistant hypertension.
Ott et al. (2018) conducted a cohort in Treatment resistant hypertension (TRH) (n=94). Renal denervation (RDN) was evaluated on Brachial and central ambulatory blood pressure (p=<.001). Renal denervation significantly reduced brachial and central ambulatory blood pressure (P<.001) and improved arterial stiffness and total vascular resistance at up to 12 months.